Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1602
| Despition | AKR7A2 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered clear colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1107 | Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107) | 50 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1592 | Human CRYAB Protein (AC1592) | 20 µg | inquiry |
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg | inquiry |
| ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
| ACPP-1138 | Recombinant Human Semaphorin 7a Protein (6×His Tag) (AC1138) | 50 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1609 | Human CNTF Protein, His (AC1609) | 5 µg | inquiry |
| ACPP-1141 | Recombinant Human Prion Protein PrP Protein (Fc Tag) (AC1141) | 50 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.